ArticleSurgery today2026
Preoperative C-reactive protein-to-albumin ratio for perioperative risk stratification in penetrating crohn's disease: identification of a candidate rule-out threshold (a propensity score-matched cohort study).
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDetermining the optimal timing of surgery for Crohn disease (CD) is challenging. The C-reactive protein-to-albumin ratio (CAR) is inexpensive and widely available; however, its utility in determining surgical timing remains unclear.
methodsWe retrospectively analyzed 112 cases of penetrating-type CD resection (screened 2010-2024). Preoperative CAR was measured within 7 days of surgery. A receiver operating characteristic analysis defined the CAR threshold to maximize the negative predictive value (NPV) for 30-day complications. Patients were categorized as having a low or high CAR and were matched 1:1 using propensity scores. The early morbidity and 5-year re-operation-free survival rates were compared.
resultsA CAR cutoff value of 0.102 yielded the highest NPV. A high CAR was associated with increased overall morbidity (55% vs. 20%) and increased wound infection (21% vs. 5%). After matching (25 pairs), a high CAR was correlated with more complications (52% vs. 24%; P = 0.04) and prolonged stay (median 17 vs. 11 days; P = 0.02). The five-year reoperation risk was higher with a high CAR (14.6% vs. 4.0%; P = 0.03).
conclusionsPreoperative CAR < 0.102 indicates a candidate rule-out threshold for elective CD surgery, predicting fewer early complications and a lower 5-year re-operation rate. Because CAR is rapidly available and treatment-agnostic, serial monitoring could support a testable preoperative timing framework. Further prospective validation is required.
Indexed as
Identifiers
41364160What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.